Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $4.6M | $5.5M | $1.7M | $2.0M |
| Cost of revenue | $0 | $0 | $0 | $392.7K | $917.9K | $2.7M | $4.9M | $2.1M |
| Gross profit | $0 | $0 | $0 | −$392.7K | $3.7M | $2.8M | −$3.2M | −$137.2K |
| Gross margin | — | — | — | — | 80.2% | 50.6% | -191.8% | -6.9% |
| R&D | $648 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$809.2K | −$724.2K | −$2.5M | −$3.4M | $1.6M | $287.1K | −$5.0M | −$1.6M |
| EBITDA | −$801.6K | −$713.0K | −$2.5M | −$3.0M | $2.3M | $997.3K | −$4.1M | −$990.5K |
| Net income | −$809.2K | −$724.2K | −$2.5M | −$2.7M | $1.5M | $241.1K | −$4.8M | −$1.9M |
| Net margin | — | — | — | — | 32.3% | 4.4% | -284.9% | -93.7% |
| EPS (diluted) | -0.03 | -0.02 | -0.05 | -0.04 | 0.02 | 0.00 | -0.05 | -0.02 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds LTTSF.
No tracked institution reports a position in LTTSF as of their last filing.
No one on the platform has traded LTTSF yet.
| $447175 |
| — |
| LAXAFLaxai Pharma, Ltd. | $0.00 | +0.00% | $475341 | — |
| MSITFMedical Services International Inc. | $0.00 | +0.00% | $480000 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.